As part of this Investor Webinar, Emyria Managing Director, Dr Michael Winlo, explains the significance of Emyria’s data validated care model and its potential impact in reducing opioid consumption.

This includes an overview of the Company’s recent ASX release, “Emyria Data Validated, Care Model Reduces Opioids”, and preliminary results of a collaboration between Emyria, IQVIA (NYSE:IQV) and NostraData.

Watch the 21-minute webinar here.